Altimmune (ALT) Market Capitalization (2017 - 2026)
Altimmune's Market Capitalization came in at $591.2 million for Q2 2026, up 79.6% from $329.25 million a year earlier and up 47.4% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Market Capitalization (2017 - 2026) Analysis & Trends
For FY2025, Altimmune's Market Capitalization was $318.06 million, down 39.0% from FY2024.
- Market Capitalization has declined in each of the last three years, though with a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $521.66 million in FY2024 (-12.9%), $599.03 million in FY2023 (-26.0%), $809.34 million in FY2022 (+115.5%) and $375.5 million in FY2021 (+29.8%).
- The Q2 2026 figure represents the highest quarterly Market Capitalization since Q1 2024.
- Year-over-year, Market Capitalization increased in three of the last eight quarters, with growth averaging 19.3%.
- The fastest year-over-year change in Market Capitalization over five years came in Q1 2024 (growth of 247.0%), and the weakest in Q3 2023 (a decline of 78.1%).
- Business Quant data shows ALT's Market Capitalization at $401.08 million (Q1 2026), $318.06 million (Q4 2025) and $360.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Altimmune | 377.28 Mn | -764.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 591.20 Mn |
| Mar 31, 2026 | 401.08 Mn |
| Dec 31, 2025 | 318.06 Mn |
| Sep 30, 2025 | 360.41 Mn |
| Jun 30, 2025 | 329.25 Mn |
| Mar 31, 2025 | 389.13 Mn |
| Dec 31, 2024 | 521.66 Mn |
| Sep 30, 2024 | 436.70 Mn |
| Jun 30, 2024 | 472.46 Mn |
| Mar 31, 2024 | 721.75 Mn |
| Dec 31, 2023 | 599.03 Mn |
| Sep 30, 2023 | 137.43 Mn |
| Jun 30, 2023 | 185.88 Mn |
| Mar 31, 2023 | 207.99 Mn |
| Dec 31, 2022 | 809.34 Mn |
| Sep 30, 2022 | 627.79 Mn |
| Jun 30, 2022 | 542.55 Mn |
| Mar 31, 2022 | 263.21 Mn |
| Dec 31, 2021 | 375.50 Mn |
| Sep 30, 2021 | 449.04 Mn |
API Access
Altimmune Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();